title: Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.
authors.affiliation: Department of Dermatology, Oregon Health and Science University, and Oregon Health and Cancer Institute, Portland, Oregon 97239, USA.
authors.forename: Khosrow
authors.initials: K
authors.lastname: Mehrany
authors.forename: Neil A
authors.initials: NA
authors.lastname: Swanson
authors.forename: Michael C
authors.initials: MC
authors.lastname: Heinrich
authors.forename: Roger H
authors.initials: RH
authors.lastname: Weenig
authors.forename: Ken K
authors.initials: KK
authors.lastname: Lee
authors.forename: Clifton R
authors.initials: CR
authors.lastname: White
authors.forename: Theresa S
authors.initials: TS
authors.lastname: Devere
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002610:Cheek; D018223:Dermatofibrosarcoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005153:Facial Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate